KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update
(NASDAQ: KALV) Delayed: 27.00 --0 (-0%)
Previous Close $27.00    52 Week High $ 
Open $27.00    52 Week Low $ 
Day High $27.00    P/E N/A 
Day Low $27.00    EPS $ 
Volume 10,757